USCA’s policy basis focuses on the lack of sufficient research to understand long-term risks associated with mRNA technologies.

USPOULTRY Foundation Research Advisory Committee will host a webinar to provide an overview of the request for proposals.

Losses stemming from disease cost the U.S. cattle industry more than $1 billion annually.

A collaboration between Renaissance BioScience and the Vaccine and Infectious Disease Organization targets two diseases, as well as immune system function, in pigs and piglets.

NIAA offers animal agriculture stakeholders an mRNA information brief and infographic.

Medgene's vaccine approach leverages a USDA-approved 'platform technology' that is safe and easily adapted to multiple animal disease targets.

Mazen’s PEDV patent builds on an established portfolio that covers the underlying platform technology developed by John Howard, Ph.D., one of the company’s founders.

Dr. Candida Cabral has a strong background in plant breeding, molecular biology, and genetics.

The research project provided two significant value-added findings that may lead to the development of a more effective ILT vaccine for the industry.

Tyson Foods provides safer, healthier environment for frontline workers as they continue to feed the nation.